Hidden ESR1 Mutations Signal Trouble Before Breast Cancer Progresses
A large U.S. real-world study found that ESR1 mutations emerging during first-line therapy for ER-positive metastatic breast cancer are linked ...
Tag: CDK4/6 inhibitors
Biomarkers Predict Response to Palbociclib-Anastrozole Therapy
In an intense and promising leap forward in the fight against breast cancer, researchers have unveiled groundbreaking findings on the ...
BLU-222 Boosts CDK4/6 Inhibitors in Resistant Breast Cancer
In a groundbreaking development in the battle against breast cancer, researchers have unveiled a novel therapeutic strategy that could redefine ...
Gene Panel Predicts Response to Crucial Breast Cancer Therapy
Researchers unveil a groundbreaking immune-based genomic signature that promises to revolutionize treatment strategies for hormone receptor-positive, HER2-negative breast cancer by ...
CDK4/6 Inhibitors Boost First-Line Breast Cancer Therapy
In an ambitious stride toward optimizing treatment for hormone receptor-positive (HR+)/HER2-negative advanced breast cancer, a recent comprehensive network meta-analysis has ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!